Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

204
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
204
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

611
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
611
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

110
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
110
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

1.5K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.5K
Pore Size Distribution01:23

Pore Size Distribution

361
In concrete, the pore size distribution significantly influences the material's properties. Capillary pores, markedly larger than gel pores, form a vast network within partially hydrated cement paste, reducing the concrete's strength and increasing its permeability. This heightened permeability leads to a greater risk of damage from environmental factors like freeze-thaw cycles and chemical attacks, with the extent of vulnerability also being tied to the water-to-cement ratio.
Adequate...
361
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

8.1K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From R&D to production: Scale-out of continuous spin-freeze-drying for a PEGylated peptide formulation.

International journal of pharmaceutics·2026
Same author

PhaLP 2.0: extending the community-oriented phage lysin database with a SUBLYME pipeline for metagenomic discovery.

Database : the journal of biological databases and curation·2026
Same author

Mechanistic understanding of drug release in dissolution apparatuses - In-depth review.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Predicting the tabletability of binary mixtures from individual powder compaction behavior.

International journal of pharmaceutics·2026
Same author

In-Line Blend Potency Measurements of Low-Dose Formulations Using a Novel Deep-UV LIF Probe in the Feed Frame of a Rotary Tablet Press.

Analytical chemistry·2026
Same author

An integrated framework streamlining the manufacturing of high drug loading pharmaceutical tablets.

International journal of pharmaceutics·2026
Same journal

RETRACTED: Meligy et al. Therapeutic Potential of Mesenchymal Stem Cells Versus Omega n - 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration. <i>Pharmaceutics</i> 2022, <i>14</i>, 1322.

Pharmaceutics·2026
Same journal

Correction: Mohite et al. Bioactive Compound-Fortified Nanomedicine in the Modulation of Reactive Oxygen Species and Enhancement of the Wound Healing Process: A Review. <i>Pharmaceutics</i> 2025, <i>17</i>, 855.

Pharmaceutics·2026
Same journal

Metal Nanoparticle-Reinforced Hydrogels Applied in the Inhibition of Clinical Pathogens: Structural Features, Mechanisms, and Biomedical Prospects.

Pharmaceutics·2026
Same journal

Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Cipepofol Across Diverse Clinical Populations.

Pharmaceutics·2026
Same journal

Artificial Intelligence in Nanopharmaceutical Development: From Predictive Design to Clinical Translation.

Pharmaceutics·2026
Same journal

Textilinin-1, a Snake Venom-Derived Kunitz-Type Protease Inhibitor, Accelerates Wound Healing Through Anti-Inflammatory, Antibacterial, and Pro-Regenerative Activities.

Pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: Dec 26, 2025

Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes
04:40

Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes

Published on: July 7, 2023

3.0K

Predicting Pharmaceutical Particle Size Distributions Using Kernel Mean Embedding.

Daan Van Hauwermeiren1,2, Michiel Stock3, Thomas De Beer2

  • 1BIOMATH - Department of data analysis and mathematical modelling, Ghent University, Coupure Links 653, 9000 Gent, Belgium.

Pharmaceutics
|March 20, 2020
PubMed
Summary
This summary is machine-generated.

A new data-driven model predicts pharmaceutical granule size distributions from wet granulation settings. This framework aids quality control and process optimization in continuous manufacturing.

Keywords:
continuous manufacturingdata-drivengranulationkernel mean embeddingkernel methodsmachine learningparticle size distributionspredictive modelingprocess modelingwet granulation

More Related Videos

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

66.3K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.7K

Related Experiment Videos

Last Updated: Dec 26, 2025

Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes
04:40

Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes

Published on: July 7, 2023

3.0K
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

66.3K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.7K

Area of Science:

  • Pharmaceutical Manufacturing
  • Chemical Engineering
  • Data Science

Background:

  • Continuous manufacturing is increasingly adopted in the pharmaceutical industry for solid dosage forms.
  • High-quality process models are crucial for optimizing continuous pharmaceutical manufacturing processes.
  • Understanding particle size distribution changes in wet granulation is essential for downstream processing, like fluid bed drying.

Purpose of the Study:

  • To develop a data-driven modeling framework linking wet granulation machine settings to granule output distributions.
  • To enable prediction of particle size distributions without assumptions about their nature.
  • To provide a simulation tool for granule size distribution as a soft sensor.

Main Methods:

  • A two-step data-driven approach was employed.
  • Measured particle size distributions were transformed into a high-dimensional feature space.
  • Machine settings and output distributions were related in this feature space, followed by inverse transformation for interpretation.

Main Results:

  • A validated data-driven framework for predicting pharmaceutical particle size distributions was established.
  • The model effectively links wet granulation process settings to granule size output distributions.
  • The approach allows for interpretation in the original measurement space, facilitating understanding.

Conclusions:

  • The developed data-driven framework reliably predicts pharmaceutical particle size distributions.
  • This predictive capability is vital for quality assurance and troubleshooting in pharmaceutical production lines.
  • The framework supports applications like model-based experimental design and real-time model predictive control.